Abeer Selim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Abeer Selim has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Hala Tabie El-Bassyouni
Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt
3 shared publications Aliaa Ahmed Wahby
2 shared publications- Alshaymaa Ahmed Ibrahim
Clinical and Chemical Pathology Department, National Research Centre, Cairo, Egypt
2 shared publications - Eman Refaat Youness
Medical Biochemistry Department, Medical Research Institute, National Research Centre, Cairo, Egypt
2 shared publications Mohamed G. Shouman
2 shared publications- Moushira Erfan Zaki
Biological Anthropology Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt
2 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 3 (19) , 2292-2299
Association of Serum TNF-α and HSP-70 with Serologic and Cutaneous Manifestations in Pediatric Celiac Disease
Celiac disease is a gluten-triggered chronic autoimmune disorder occurring in genetically susceptible individuals. Several inflammatory cytokines, including tumor necrosis factor (TNF-α), showed elevated levels, contributing to CD pathogenesis and its aggravation. Heat shock protein -70 (HSP-70) is stress-induced chaperones that protect cells against injurious extracellular factors and have emerged as drug targets for autoimmune syndromes. We aimed to examine the role of TNF-α and HSPs in the pathophysiology of CD. Thirty-five children with celiac disease (22 females and 13 males) and 40 healthy controls matching age and sex were included in this case-control study. Using commercially available kits, serum anti-tissue transglutaminase antibodies, TNF-α, and HSP-70 were measured by ELISA, and HPLC measured total IgA. The mean patients’ age at diagnosis was (5 ± 3.11) years. They mainly presented with gastrointestinal symptoms. The mean serum levels of TNF-α (157.36±18.87 pg/ml) and Heat shock protein—70 (113.34±18.77 ng/ml) were significantly increased (p= 0.001) in children with celiac disease compared to healthy controls (101.11±15.39, 62.79± 21.31) respectively. A significant positive correlation between TNF-α, HSP-70, and anti-tissue transglutaminase antibodies was delineated in children with celiac disease. Skin manifestations were present in 34.3% of CD patients. Despite the relatively small sample size, this study elucidates the association of elevated TNF-alpha and HSP-70 with celiac disease in children. Additionally, the present results elucidated the association between CD and skin manifestations.
- 30 September 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 3 (19) , 2292-2299
Open AccessAssociation of Serum TNF-α and HSP-70 with Serologic and Cutaneous Manifestations in Pediatric Celiac Disease
Celiac disease is a gluten-triggered chronic autoimmune disorder occurring in genetically susceptible individuals. Several inflammatory cytokines, including tumor necrosis factor (TNF-α), showed elevated levels, contributing to CD pathogenesis and its aggravation. Heat shock protein -70 (HSP-70) is stress-induced chaperones that protect cells against injurious extracellular factors and have emerged as drug targets for autoimmune syndromes. We aimed to examine the role of TNF-α and HSPs in the pathophysiology of CD. Thirty-five children with celiac disease (22 females and 13 males) and 40 healthy controls matching age and sex were included in this case-control study. Using commercially available kits, serum anti-tissue transglutaminase antibodies, TNF-α, and HSP-70 were measured by ELISA, and HPLC measured total IgA. The mean patients’ age at diagnosis was (5 ± 3.11) years. They mainly presented with gastrointestinal symptoms. The mean serum levels of TNF-α (157.36±18.87 pg/ml) and Heat shock protein—70 (113.34±18.77 ng/ml) were significantly increased (p= 0.001) in children with celiac disease compared to healthy controls (101.11±15.39, 62.79± 21.31) respectively. A significant positive correlation between TNF-α, HSP-70, and anti-tissue transglutaminase antibodies was delineated in children with celiac disease. Skin manifestations were present in 34.3% of CD patients. Despite the relatively small sample size, this study elucidates the association of elevated TNF-alpha and HSP-70 with celiac disease in children. Additionally, the present results elucidated the association between CD and skin manifestations.
- Open Access
- 28 October 2025
- Published by Walter de Gruyter GmbH in Journal of Complementary and Integrative Medicine
- Vol. 23 (2) , 349-356
Serum TNF-α, oxidized LDL, and APOCII as novel predictors for familial mediterranean fever in Egyptian children: a cross-sectional study
Persistent subclinical inflammation is a hallmark of familial Mediterranean fever (FMF), the most common autoinflammatory disease. Among the key mediators implicated in this chronic inflammatory state are tumor necrosis factor-alpha (TNF-α), oxidized low-density lipoprotein (OxLDL), and apolipoprotein C-II (APOC2), which contribute to the dysregulated immune response characteristic of FMF. The present study aims to evaluate the potential role of TNF-α, OxLDL, and APOC2 as diagnostic biomarkers of disease severity in patients with FMF. Methods: The study enrolled 66 patients diagnosed with FMF and 60 age- and gender-matched healthy controls. Serum levels of tumor necrosis factor-alpha (TNF-α) and oxidized low-density lipoprotein (OxLDL) were quantified using the enzyme-linked immunosorbent assay (ELISA) technique. However, the apolipoprotein C-II (APOC2) concentrations were measured using an automated biochemistry analyzer. Furthermore, the Carotid intima media was assessed. Results: Serum TNF-α levels were significantly higher in FMF patients than in the control group, emphasizing the protein’s role as an important marker of chronic inflammation. Levels of low-density lipoprotein (OxLDL) and apolipoprotein C-II (APOC2) were also notably altered in the FMF cohort. Notably, OxLDL, APOC2 and TNF-α demonstrated strong positive correlation with attack frequency, multiple linear regressions analysis showed that OxLDL (β=1.53, p=0.002) and TNF-α (β=1.38, p=0.003) were significant predictors for higher number of attacks, suggesting their potential role involvement in the inflammatory cascade and their utility as complementary biomarkers in FMF. The carotid intima-media thickness (CIMT) of patients and control subjects did not differ statistically significantly. Conclusions: TNF-α, oxidized LDL, and APOC2 are key pro-inflammatory mediators that may serve as novel biomarkers for assessing chronic inflammatory status in FMF patients. Their elevated levels could provide valuable insights into disease progression and help guide personalized treatment strategies.
- 28 October 2025
- Published by Walter de Gruyter GmbH in Journal of Complementary and Integrative Medicine
- Vol. 23 (2) , 349-356
Open AccessSerum TNF-α, oxidized LDL, and APOCII as novel predictors for familial mediterranean fever in Egyptian children: a cross-sectional study
Persistent subclinical inflammation is a hallmark of familial Mediterranean fever (FMF), the most common autoinflammatory disease. Among the key mediators implicated in this chronic inflammatory state are tumor necrosis factor-alpha (TNF-α), oxidized low-density lipoprotein (OxLDL), and apolipoprotein C-II (APOC2), which contribute to the dysregulated immune response characteristic of FMF. The present study aims to evaluate the potential role of TNF-α, OxLDL, and APOC2 as diagnostic biomarkers of disease severity in patients with FMF. Methods: The study enrolled 66 patients diagnosed with FMF and 60 age- and gender-matched healthy controls. Serum levels of tumor necrosis factor-alpha (TNF-α) and oxidized low-density lipoprotein (OxLDL) were quantified using the enzyme-linked immunosorbent assay (ELISA) technique. However, the apolipoprotein C-II (APOC2) concentrations were measured using an automated biochemistry analyzer. Furthermore, the Carotid intima media was assessed. Results: Serum TNF-α levels were significantly higher in FMF patients than in the control group, emphasizing the protein’s role as an important marker of chronic inflammation. Levels of low-density lipoprotein (OxLDL) and apolipoprotein C-II (APOC2) were also notably altered in the FMF cohort. Notably, OxLDL, APOC2 and TNF-α demonstrated strong positive correlation with attack frequency, multiple linear regressions analysis showed that OxLDL (β=1.53, p=0.002) and TNF-α (β=1.38, p=0.003) were significant predictors for higher number of attacks, suggesting their potential role involvement in the inflammatory cascade and their utility as complementary biomarkers in FMF. The carotid intima-media thickness (CIMT) of patients and control subjects did not differ statistically significantly. Conclusions: TNF-α, oxidized LDL, and APOC2 are key pro-inflammatory mediators that may serve as novel biomarkers for assessing chronic inflammatory status in FMF patients. Their elevated levels could provide valuable insights into disease progression and help guide personalized treatment strategies.
- 1 December 2020
- Published by Elsevier in Gene Reports
- Vol. 21
Perforin A and granzyme B as non invasive markers in early acute rejection in pediatric renal transplantation
- 1 December 2020
- Published by Elsevier in Gene Reports
- Vol. 21
Perforin A and granzyme B as non invasive markers in early acute rejection in pediatric renal transplantation
- 1 September 2020
- Published by Elsevier in Gene Reports
- Vol. 20
A descriptive study of NPHS1 and NPHS2 mutations in children with congenital nephrotic syndrome
- 1 September 2020
- Published by Elsevier in Gene Reports
- Vol. 20
A descriptive study of NPHS1 and NPHS2 mutations in children with congenital nephrotic syndrome
- Open Access
- 10 December 2019
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 7 (23) , 3955-3959
Oxidative Stress in Hemodialysis Pediatric Patients
BACKGROUND: Oxidative stress may play a role in complications of hemodialysis patients as atherosclerosis, thrombosis, and inflammation. AIM: The aim of the study was to evaluate the oxidative stress in hemodialysis pediatric patients through measurement of oxidative stress enzymes as paraoxanase activity (PON), arylesterase activity (ASA), superoxide dismutase (SOD) and also non-enzymatic antioxidant vitamins as vitamins A, C and E levels. METHODS: The study included 50 hemodialysis pediatric patients with mean age 11.4 ± 5.4 years and 30 normal children of matched sex and age as a control group. Assessment of oxidative stresses was done using ELIZA technique. RESULTS: SOD, ASA, and vitamin C were significantly lower among hemodialysis patients in comparison to control group (p = 0.004, 0.004, > 0.001 respectively). CONCLUSION: The study concluded that oxidative stress was common finding in hemodialysis pediatric patients which may play a role in complications encountered among these patients.
- 10 December 2019
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 7 (23) , 3955-3959
Open AccessOxidative Stress in Hemodialysis Pediatric Patients
BACKGROUND: Oxidative stress may play a role in complications of hemodialysis patients as atherosclerosis, thrombosis, and inflammation. AIM: The aim of the study was to evaluate the oxidative stress in hemodialysis pediatric patients through measurement of oxidative stress enzymes as paraoxanase activity (PON), arylesterase activity (ASA), superoxide dismutase (SOD) and also non-enzymatic antioxidant vitamins as vitamins A, C and E levels. METHODS: The study included 50 hemodialysis pediatric patients with mean age 11.4 ± 5.4 years and 30 normal children of matched sex and age as a control group. Assessment of oxidative stresses was done using ELIZA technique. RESULTS: SOD, ASA, and vitamin C were significantly lower among hemodialysis patients in comparison to control group (p = 0.004, 0.004, > 0.001 respectively). CONCLUSION: The study concluded that oxidative stress was common finding in hemodialysis pediatric patients which may play a role in complications encountered among these patients.
- Open Access
- 27 November 2019
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 67 (1)
Apolipoprotein E and plasminogen activator inhibitor 1 gene polymorphism in children with chronic renal insufficiency associated with cardiovascular disease
Background: Cardiovascular disease (CVD) is considered a major cause of death in renal insufficiency (RI). Contributing genetic factors is a recent focus of research. This study aims to elucidate apolipoprotein E (APO-E) and plasminogen activator inhibitor 1 (PAI-1) gene polymorphisms in RI children associated with CVD.Methods: We studied 50 cases with chronic kidney disease (CKD) associated with CVD, and 30 healthy controls. Study sample was grouped as one on conservative treatment, the second on hemodialysis and the third was posttransplant. PAI-1 and APO-E gene polymorphisms were investigated using allele-specific polymerase chain reaction (AS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) respectively.Results: 4G4G and 4G5G were the most common PAI-1 polymorphism denoting high association of 4 G allele in renal insufficiency associated with CVD with absent link to dyslipidemia, echocardiography changes or thrombosis. E3E3 was the most common among APO-E polymorphism without relation to dyslipidemia or thrombosis. Dyslipidemia was significantly linked to thrombosis. The study confirmed the role of dyslipidemia and hemodialysis in promoting thrombosis.Conclusion: Although PAI 4G Genotyping did not show significant association with echocardiography severity or thrombotic severity, yet genetic expression for high levels of PAI in plasma is expected in response to CRI factors known to trigger its release, in addition to those related to dialysis. APO-E3E3 genotyping showed a significant association with echocardiography severity as it enhances APO-A which contributes to CVD. The current study confirmed a significant association between dyslipidemia and CVD; however, the prevalent patterns 4G and E3E3 did not show a significant association with dyslipidemia. The genetic role for APO-A, B, O, or even other isomers for APO-E should be further studied as well.
- 27 November 2019
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 67 (1)
Open AccessApolipoprotein E and plasminogen activator inhibitor 1 gene polymorphism in children with chronic renal insufficiency associated with cardiovascular disease
Background: Cardiovascular disease (CVD) is considered a major cause of death in renal insufficiency (RI). Contributing genetic factors is a recent focus of research. This study aims to elucidate apolipoprotein E (APO-E) and plasminogen activator inhibitor 1 (PAI-1) gene polymorphisms in RI children associated with CVD.Methods: We studied 50 cases with chronic kidney disease (CKD) associated with CVD, and 30 healthy controls. Study sample was grouped as one on conservative treatment, the second on hemodialysis and the third was posttransplant. PAI-1 and APO-E gene polymorphisms were investigated using allele-specific polymerase chain reaction (AS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) respectively.Results: 4G4G and 4G5G were the most common PAI-1 polymorphism denoting high association of 4 G allele in renal insufficiency associated with CVD with absent link to dyslipidemia, echocardiography changes or thrombosis. E3E3 was the most common among APO-E polymorphism without relation to dyslipidemia or thrombosis. Dyslipidemia was significantly linked to thrombosis. The study confirmed the role of dyslipidemia and hemodialysis in promoting thrombosis.Conclusion: Although PAI 4G Genotyping did not show significant association with echocardiography severity or thrombotic severity, yet genetic expression for high levels of PAI in plasma is expected in response to CRI factors known to trigger its release, in addition to those related to dialysis. APO-E3E3 genotyping showed a significant association with echocardiography severity as it enhances APO-A which contributes to CVD. The current study confirmed a significant association between dyslipidemia and CVD; however, the prevalent patterns 4G and E3E3 did not show a significant association with dyslipidemia. The genetic role for APO-A, B, O, or even other isomers for APO-E should be further studied as well.
- Open Access
- 1 October 2019
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 60 (5) , 537-542
Effect of packed red blood cell transfusion on IL-8 and sICAM-1 in premature neonates at different postnatal ages
- 1 October 2019
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 60 (5) , 537-542
Open AccessEffect of packed red blood cell transfusion on IL-8 and sICAM-1 in premature neonates at different postnatal ages
- Open Access
- 11 June 2017
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 5 (3) , 299-304
Study of Visfatin Level in Type 1 Diabetic Children and Adolescents
BACKGROUND: Visfatin is an intracellular enzyme, known as nicotinamide phosphoribosyltransferase (Nampt) and pre-B-cell colony-enhancing factor (PBEF-1). It has insulin-mimetic effects and lowers plasma glucose levels.AIM: The aim of the work was to assess serum concentration of Visfatin in type 1 diabetic children and adolescents and study its relationships with duration of diabetes, body mass index (BMI), glycemic control, insulin dosage, lipid profile and microvascular complications.MATERIAL AND METHODS: Fifty children and adolescents with type 1 diabetes mellitus were recruited with 30 ages and gender-matched healthy subjects. They were subjected to history taking; anthropometric measurements and chronic diabetic complications were recorded if present. Laboratory analysis included urinary microalbumin, serum triglycerides, HDL, LDL, cholesterol, fasting blood glucose, glycosylated Hb (HbA1c) and serum visfatin which was measured with enzyme-linked immunosorbent assay.RESULTS: Diabetic patients showed highly significant decrease in the level of visfatin compared to the control group (P = 0.0001).There was significant further decrease in visfatin level in diabetics with microalbuminuria (n = 13) compared to normoalbuminuric patients (n = 37) (P = 0.015). There was highly significant inverse correlation between visfatin level with age (r = -0.379, p = 0.007), BMI (r = -0.418, p = 0.003), waist circumference (r = -0.430, p = 0.002), hip circumference (r = -0.389, p = 0.005) and microalbuminuria (r = -0.323, p = 0.022).CONCLUSIONS: Type 1 diabetic children and adolescents had a significantly lower visfatin level compared to controls. A marked decrease in the level of visfatin was shown in patients with microalbuminuria with an inverse correlation with BMI suggesting an important role of visfatin in the pathogenesis of type 1 diabetics and type 1 diabetic nephropathy.
- 11 June 2017
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 5 (3) , 299-304
Open AccessStudy of Visfatin Level in Type 1 Diabetic Children and Adolescents
BACKGROUND: Visfatin is an intracellular enzyme, known as nicotinamide phosphoribosyltransferase (Nampt) and pre-B-cell colony-enhancing factor (PBEF-1). It has insulin-mimetic effects and lowers plasma glucose levels.AIM: The aim of the work was to assess serum concentration of Visfatin in type 1 diabetic children and adolescents and study its relationships with duration of diabetes, body mass index (BMI), glycemic control, insulin dosage, lipid profile and microvascular complications.MATERIAL AND METHODS: Fifty children and adolescents with type 1 diabetes mellitus were recruited with 30 ages and gender-matched healthy subjects. They were subjected to history taking; anthropometric measurements and chronic diabetic complications were recorded if present. Laboratory analysis included urinary microalbumin, serum triglycerides, HDL, LDL, cholesterol, fasting blood glucose, glycosylated Hb (HbA1c) and serum visfatin which was measured with enzyme-linked immunosorbent assay.RESULTS: Diabetic patients showed highly significant decrease in the level of visfatin compared to the control group (P = 0.0001).There was significant further decrease in visfatin level in diabetics with microalbuminuria (n = 13) compared to normoalbuminuric patients (n = 37) (P = 0.015). There was highly significant inverse correlation between visfatin level with age (r = -0.379, p = 0.007), BMI (r = -0.418, p = 0.003), waist circumference (r = -0.430, p = 0.002), hip circumference (r = -0.389, p = 0.005) and microalbuminuria (r = -0.323, p = 0.022).CONCLUSIONS: Type 1 diabetic children and adolescents had a significantly lower visfatin level compared to controls. A marked decrease in the level of visfatin was shown in patients with microalbuminuria with an inverse correlation with BMI suggesting an important role of visfatin in the pathogenesis of type 1 diabetics and type 1 diabetic nephropathy.
- 1 August 2007
- Published by Egyptian Knowledge Bank in GEGET
- Vol. 7 (1) , 13-20
Ceruloplasmin : a Possible Predictor of Pediatric Renal Vasculitides.
Background: Diagnosis of vasculitides remains of paramount importance to ensure appropriate management. Ceruloplasmin is an acute phase protein that has antiprotease and antioxidant properties and inhibits myeloperoxidase. Objectives: This study has been undertaken to assess the potential role of ceruloplasmin as a marker of pediatric renal vasculitis. Methods: Ceruloplasrnin was studied in 80 subjects between 5 and 15 years of age with different clinical Conditions potentially associated with renal vasculitis and 20 controls. Cases included 30 patients with nephritic syndrome: 10 with rapidly progressive glomerulonephritis (RPGN), 20 with systemic lupus and 20 with other vasculitis syndromes. Results: Ceruloplasrnin was significantly elevated in those with nephritis, lupus nephritis and RPGN. Those with positive ANCA (18 cases) had higher ceruloplasmin (0.51 * 0.3 g/L compared to 0.35 * 0.2 g/L in negative cases. p = 0.01). Those with pANCA had even higher levels (0.62 * 0.3 g/L). Those with biopsy evidence of vasculitis had higher ceruloplasmin than those without (0.46 * 0.3 g/L and 0.28 * 0.07 g/L respectively, p = 0.0 I). Conclusion: Ceruoplasmin is elevated in children with renal vasculitis and may be a useful non-invasive diagnostic test.
- 1 August 2007
- Published by Egyptian Knowledge Bank in GEGET
- Vol. 7 (1) , 13-20
Ceruloplasmin : a Possible Predictor of Pediatric Renal Vasculitides.
Background: Diagnosis of vasculitides remains of paramount importance to ensure appropriate management. Ceruloplasmin is an acute phase protein that has antiprotease and antioxidant properties and inhibits myeloperoxidase. Objectives: This study has been undertaken to assess the potential role of ceruloplasmin as a marker of pediatric renal vasculitis. Methods: Ceruloplasrnin was studied in 80 subjects between 5 and 15 years of age with different clinical Conditions potentially associated with renal vasculitis and 20 controls. Cases included 30 patients with nephritic syndrome: 10 with rapidly progressive glomerulonephritis (RPGN), 20 with systemic lupus and 20 with other vasculitis syndromes. Results: Ceruloplasrnin was significantly elevated in those with nephritis, lupus nephritis and RPGN. Those with positive ANCA (18 cases) had higher ceruloplasmin (0.51 * 0.3 g/L compared to 0.35 * 0.2 g/L in negative cases. p = 0.01). Those with pANCA had even higher levels (0.62 * 0.3 g/L). Those with biopsy evidence of vasculitis had higher ceruloplasmin than those without (0.46 * 0.3 g/L and 0.28 * 0.07 g/L respectively, p = 0.0 I). Conclusion: Ceruoplasmin is elevated in children with renal vasculitis and may be a useful non-invasive diagnostic test.